Medical specialists from Australia tagged as investigators in clinical trials studying Carcinoma, Renal Cell
Total 19 results
-
Alison Zhang, MDSeen in:
- New South Wales, Macquarie Park, Macquarie University Hospital
Trials:- NCT05013099 (Principal Investigator)
-
Andrew ScottSeen in:
- Melbourne, Austin Health
- Victoria, Heidelberg, Austin Health
- Victoria, Heidelberg, Olivia Newton-John Cancer Research Insititute
Trials:- NCT04127981 (Principal Investigator)
- NCT05868174 (Principal Investigator)
- NCT05013099 (Principal Investigator)
-
Arun Azad, MDSeen in:
- Melbourne, Peter MacCallum Cancer Centre
Trials:- NCT04090710 (Principal Investigator)
Conditions: -
Bhavna PadhyeSeen in:
- New South Wales, Hunter Regional Mail Centre, John Hunter Children's Hospital
- New South Wales, Randwick, Sydney Children's Hospital
- New South Wales, Westmead, The Children's Hospital at Westmead
Trials:- NCT04759586 (Principal Investigator)
- NCT04238819 (Principal Investigator)
- NCT05457556 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03533582 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT05304585 (Principal Investigator)
- NCT04684368 (Principal Investigator)
- NCT05235165 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT00898365 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT00772200 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Relapsed Solid Tumor;
- Refractory Solid Tumor;
- Acute Myeloid Leukemia;
- Acute Lymphoblastic Leukemia;
- Myelodysplastic Syndrome;
- Mixed Phenotype Acute Leukemia;
- Recurrent Neuroblastoma;
- Refractory Neuroblastoma;
- High Risk Neuroblastoma;
- Hepatoblastoma;
- Fibrolamellar Carcinoma;
- Childhood Hepatocellular Carcinoma;
- Childhood Malignant Liver Neoplasm;
- Hepatocellular Malignant Neoplasm, Not Otherwise Specified;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- T Acute Lymphoblastic Leukemia;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Embryonal Rhabdomyosarcoma;
- Fusion-Negative Alveolar Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Choriocarcinoma;
- Embryonal Carcinoma;
- Mixed Germ Cell Tumor;
- Central Nervous System Nongerminomatous Germ Cell Tumor;
- Immature Teratoma;
- Malignant Teratoma;
- Pineal Region Germ Cell Tumor;
- Pineal Region Immature Teratoma;
- Pineal Region Yolk Sac Tumor;
- Suprasellar Germ Cell Tumor;
- Osteosarcoma;
- Metastatic Osteosarcoma;
- Metastatic Malignant Neoplasm in the Lung;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive;
- Juvenile Myelomonocytic Leukemia;
- Myeloid Leukemia Associated With Down Syndrome;
- Acute Myeloid Leukemia Post Cytotoxic Therapy;
- Myelodysplastic Syndrome Post Cytotoxic Therapy;
- Renal Cell Carcinoma;
- Wilms Tumor;
- Clear Cell Sarcoma of the Kidney;
- Papillary Renal Cell Carcinoma;
- Kidney Medullary Carcinoma;
- Diffuse Hyperplastic Perilobar Nephroblastomatosis;
- Rhabdoid Tumor of the Kidney;
- Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions;
- Kidney Neoplasm;
- Adult Cystic Nephroma;
- Angiolipoma;
- Cellular Congenital Mesoblastic Nephroma;
- Classic Congenital Mesoblastic Nephroma;
- Cystic Partially Differentiated Kidney Nephroblastoma;
- Extrarenal Rhabdoid Tumor;
- Kidney Oncocytoma;
- Kidney Wilms Tumor;
- Metanephric Adenofibroma;
- Metanephric Adenoma;
- Metanephric Stromal Tumor;
- Metanephric Tumor;
- Mixed Congenital Mesoblastic Nephroma;
- Ossifying Renal Tumor of Infancy;
- Alveolar Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma;
- Childhood Malignant Neoplasm
-
Dainik PatelSeen in:
- Adelaide, Ashford (Icon) Cancer Centre
Trials:- NCT05868174 (Principal Investigator)
-
Howard GurneySeen in:
- New South Wales, North Ryde, Macquarie University
- New South Wales, Westmead, Crown Princess Mary Cancer Centre, Westmead Hospital
Trials:- NCT05868174 (Principal Investigator)
- NCT01711268 (Principal Investigator)
-
Kenneth O'ByrneSeen in:
- Brisbane, Princess Alexandra Hospital
- Queensland, Brisbane, Metro South Hospital and Health Services via Princess Alexandra Hospital
- Queensland, Woolloongabba, Princess Alexandra Hospital
Trials:- NCT03994393 (Principal Investigator)
- NCT03611868 (Principal Investigator)
- NCT05505825 (Principal Investigator)
- NCT05868174 (Principal Investigator)
Conditions:- EGFR Mutant Advanced Non Small Cell Lung Cancer;
- Melanoma;
- P53 Mutation;
- Uveal Melanoma;
- Cutaneous Melanoma;
- Mucosal Melanoma;
- Malignant Peripheral Nerve Sheath Tumors;
- MPNST;
- Unresectable or Metastatic Melanoma or Advanced Solid Tumors;
- MDM2 Gene Mutation;
- SCLC,Extensive Stage;
- Advanced Solid Tumor;
- Solid Tumor, Adult;
- Advanced Renal Cell Carcinoma
-
Maria L. KirbySeen in:
- South Australia, North Adelaide, Women's and Children's Hospital-Adelaide
Trials:- NCT02724579 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT00898365 (Principal Investigator)
- NCT00904241 (Principal Investigator)
- NCT03959085 (Principal Investigator)
- NCT00082745 (Principal Investigator)
Conditions:- Medulloblastoma;
- Recurrent Neuroblastoma;
- Refractory Neuroblastoma;
- High Risk Neuroblastoma;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Renal Cell Carcinoma;
- Wilms Tumor;
- Clear Cell Sarcoma of the Kidney;
- Papillary Renal Cell Carcinoma;
- Kidney Medullary Carcinoma;
- Diffuse Hyperplastic Perilobar Nephroblastomatosis;
- Rhabdoid Tumor of the Kidney;
- Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions;
- Kidney Neoplasm;
- Adult Cystic Nephroma;
- Angiolipoma;
- Cellular Congenital Mesoblastic Nephroma;
- Classic Congenital Mesoblastic Nephroma;
- Cystic Partially Differentiated Kidney Nephroblastoma;
- Extrarenal Rhabdoid Tumor;
- Kidney Oncocytoma;
- Kidney Wilms Tumor;
- Metanephric Adenofibroma;
- Metanephric Adenoma;
- Metanephric Stromal Tumor;
- Metanephric Tumor;
- Mixed Congenital Mesoblastic Nephroma;
- Ossifying Renal Tumor of Infancy;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Regional Neuroblastoma;
- Stage 4S Neuroblastoma;
- Ganglioneuroblastoma;
- Stage 4 Neuroblastoma;
- Central Nervous System Leukemia;
- Testicular Leukemia;
- Mixed Phenotype Acute Leukemia;
- Childhood Malignant Neoplasm
-
Michael Brown, MDSeen in:
- South Australia, Adelaide, Royal Adelaide Hospital
Trials:- NCT05013099 (Principal Investigator)
-
Nat LenzoSeen in:
- Perth, GenesisCare Murdoch
Trials:- NCT05868174 (Principal Investigator)
-
Paul DeSousa, MDSeen in:
- New South Wales, Miranda, Cancer Care Foundation
Trials:- NCT05180799 (Principal Investigator)
-
Ramin AlipourSeen in:
- Victoria, Melbourne, Peter MacCallum Cancer Centre
Trials:- NCT05013099 (Principal Investigator)
-
Shanker Siva, MDSeen in:
- Melbourne, Peter MacCallum Cancer Centre
Trials:- NCT04090710 (Sub-Investigator)
Conditions: -
Steven A. ForestoSeen in:
- Queensland, South Brisbane, Queensland Children's Hospital
Trials:- NCT03533582 (Principal Investigator)
- NCT04195399 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT04684368 (Principal Investigator)
- NCT00898365 (Principal Investigator)
Conditions:- Hepatoblastoma;
- Fibrolamellar Carcinoma;
- Childhood Hepatocellular Carcinoma;
- Childhood Malignant Liver Neoplasm;
- Hepatocellular Malignant Neoplasm, Not Otherwise Specified;
- Desmoid Fibromatosis;
- Recurrent Desmoid Fibromatosis;
- Unresectable Desmoid Fibromatosis;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Choriocarcinoma;
- Embryonal Carcinoma;
- Mixed Germ Cell Tumor;
- Central Nervous System Nongerminomatous Germ Cell Tumor;
- Immature Teratoma;
- Malignant Teratoma;
- Pineal Region Germ Cell Tumor;
- Pineal Region Immature Teratoma;
- Pineal Region Yolk Sac Tumor;
- Suprasellar Germ Cell Tumor;
- Renal Cell Carcinoma;
- Wilms Tumor;
- Clear Cell Sarcoma of the Kidney;
- Papillary Renal Cell Carcinoma;
- Kidney Medullary Carcinoma;
- Diffuse Hyperplastic Perilobar Nephroblastomatosis;
- Rhabdoid Tumor of the Kidney;
- Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions;
- Anaplastic Kidney Wilms Tumor;
- Kidney Neoplasm;
- Adult Cystic Nephroma;
- Angiolipoma;
- Cellular Congenital Mesoblastic Nephroma;
- Classic Congenital Mesoblastic Nephroma;
- Cystic Partially Differentiated Kidney Nephroblastoma;
- Extrarenal Rhabdoid Tumor;
- Kidney Oncocytoma;
- Kidney Wilms Tumor;
- Metanephric Adenofibroma;
- Metanephric Adenoma;
- Metanephric Stromal Tumor;
- Metanephric Tumor;
- Mixed Congenital Mesoblastic Nephroma;
- Ossifying Renal Tumor of Infancy
-
Tom FergusonSeen in:
- Western Australia, Perth, Fiona Stanley Hospital
Trials:- NCT03280667 (Principal Investigator)
Conditions: -
Vineet Kwatra, MDSeen in:
- South Australia, Adelaide, Cancer Research South Australia
Trials:- NCT05180799 (Principal Investigator)
-
Wen Xu, MDSeen in:
- Queensland, Woolloongabba, Princess Alexandra Hospital
Trials:- NCT05013099 (Principal Investigator)
Clinical Trials on Carcinoma, Renal Cell
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Metastatic Clear Cell Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Sarcomatoid Renal Cell Carcinoma | Advanced Renal Cell Carcinoma | Unresectable Renal Cell... and other conditionsUnited States
-
Australian and New Zealand Urogenital and Prostate...RecruitingRenal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Papillary Renal Cell Carcinoma Type 1 | Papillary Renal Cell Carcinoma Type 2 | Chromophobe Renal Cell Carcinoma | Xp11.2 Translocation-Related Renal Cell CarcinomaAustralia
-
National Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell CarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMetastatic Renal Cell Carcinoma | Metastatic Clear Cell Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Sarcomatoid Renal Cell Carcinoma | Advanced Renal Cell Carcinoma | Advanced Sarcomatoid Renal...United States
-
National Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell CarcinomaUnited States, Taiwan, Australia
-
Bradley A. McGregor, MDBristol-Myers Squibb; ExelixisRecruitingRenal Cell Carcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Unclassified Renal Cell Carcinoma | Collecting Duct Renal Cell Carcinoma | Translocation Renal Cell Carcinoma | Unresectable Advanced Renal Cell Carcinoma | Metastatic Ncc Renal Cell CarcinomaUnited States
-
Jonsson Comprehensive Cancer CenterBeiGene; Driven To CureWithdrawnMetastatic Renal Cell Carcinoma | Stage IV Renal Cell Cancer AJCC v8 | Papillary Renal Cell Carcinoma | Collecting Duct Carcinoma | Unresectable Renal Cell Carcinoma | Hereditary Leiomyomatosis and Renal Cell Carcinoma | Clear Cell Papillary Renal Neoplasm | Hereditary Papillary Renal Cell Carcinoma and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingChromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Unclassified Renal Cell Carcinoma | Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma | Fumarate Hydratase Deficient Renal Cell Carcinoma | Succinate Dehydrogenase Deficient Renal Cell Carcinoma | Collecting Duct Renal...United States
-
Australian and New Zealand Urogenital and Prostate...Bristol-Myers SquibbActive, not recruitingRenal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Papillary Renal Cell Carcinoma Type 1 | Papillary Renal Cell Carcinoma Type 2 | Chromophobe Renal Cell Carcinoma | Xp11 Translocation CarcinomaAustralia
-
Peloton Therapeutics, Inc.Active, not recruitingKidney Cancer | Renal Cell Carcinoma | Renal Cancer | Renal Cell Carcinoma (RCC) | Renal Cell Cancer Metastatic | Kidney | Clear Cell Renal Cell Carcinoma (ccRCC) | Renal Cell Carcinoma Recurrent | Renal Cell Cancer, RecurrentUnited States